Economic burden and quality of life impairment increase with severity of PD

被引：121

作者：

Keränen, T

Kaakkola, S

Sotaniemi, K

Laulumaa, V

Haapaniemi, T

Jolma, T

Kola, H

Ylikoski, A

Satomaa, O

Kovanen, J

Taimela, E

Haapaniemi, H

Turunen, H

Takala, A

机构：

[1] Tampere Univ Hosp, Tampere, Finland

[2] Univ Helsinki, Cent Hosp, Helsinki, Finland

[3] Oulu Univ Hosp, Oulu, Finland

[4] Harjula Hosp, Kuopio, Finland

[5] Satatkunta Cent Hosp, Pori, Finland

[6] Koskela Hosp, Helsinki, Finland

[7] Orion Phamaceut Co, Res Ctr, Espoo, Finland

来源：

PARKINSONISM & RELATED DISORDERS | 2003年 / 9卷 / 03期

关键词：

Parkinson's disease; cost-of-illness; quality of life;

D O I：

10.1016/S1353-8020(02)00097-4

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Purpose. To define the interrelationship between cost-of-illness, quality of life (QoL) and Parkinson's disease (PD) severity in a common patient management setting in Finland. Scope. Two hundred and sixty consecutive outpatients with idiopathic PD participated. UPDRS, motor fluctuations, QoL, and the use of health care resources were measured. Direct and indirect costs were calculated. Conclusions. There is a strong relationship between QoL or cost-of-illness on the one hand, and severity of PD on the other. Treatment policies capable of reducing or delaying motor fluctuations would be expected to increase QoL and reduce some of the economic burden of PD. (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

收藏

页码：163 / 168

页数：6

相关论文

共 28 条

[1] CRITERIA FOR DIAGNOSING PARKINSONS-DISEASE [J].

CALNE, DB ;

SNOW, BJ ;

LEE, C .

ANNALS OF NEUROLOGY, 1992, 32 :S125-S127

[2] Living with a person who has Parkinson's disease: The spouse's perspective by stage of disease [J].

Carter, JH ;

Stewart, BJ ;

Archbold, PG ;

Inoue, I ;

Jaglin, J ;

Lannon, M ;

Rost-Ruffner, E ;

Tennis, M ;

McDermott, MP ;

Amyot, D ;

Barter, R ;

Cornelius, L ;

Demong, C ;

Dobson, J ;

Duff, J ;

Erickson, J ;

Gardiner, N ;

Gauger, L ;

Gray, P ;

Kanigan, B ;

Kiryluk, B ;

Lewis, P ;

Mistura, K ;

Malapira, T ;

Pay, M ;

Sheldon, C ;

Winfield, L ;

Wolfington-Shallow, K ;

Zoog, K .

MOVEMENT DISORDERS, 1998, 13 (01) :20-28

[3] The health burdens of Parkinson's disease [J].

Chrischilles, EA ;

Rubenstein, LM ;

Voelker, MD ;

Wallace, RB ;

Rodnitzky, RL .

MOVEMENT DISORDERS, 1998, 13 (03) :406-413

[4] Costs of drug treatment in Parkinson's disease [J].

Dodel, RC ;

Eggert, KM ;

Singer, MS ;

Eichhorn, TE ;

Pogarell, O ;

Oertel, WH .

MOVEMENT DISORDERS, 1998, 13 (02) :249-254

[5] The economic impact of Parkinson's disease - An estimation based on a 3-month prospective analysis [J].

Dodel, RC ;

Singer, M ;

Kohne-Volland, R ;

Szucs, T ;

Rathay, B ;

Scholz, E ;

Oertel, WH .

PHARMACOECONOMICS, 1998, 14 (03) :299-312

[6] Health-related quality of life and healthcare utilisation in patients with Parkinson's disease - Impact of motor fluctuations and dyskinesias [J].

Dodel, RC ;

Berger, K ;

Oertel, WH .

PHARMACOECONOMICS, 2001, 19 (10) :1013-1038

[7] MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE - CENTRAL PATHOPHYSIOLOGICAL MECHANISMS .1. [J].

FABBRINI, G ;

MOURADIAN, MM ;

JUNCOS, JL ;

SCHLEGEL, J ;

MOHR, E ;

CHASE, TN .

ANNALS OF NEUROLOGY, 1988, 24 (03) :366-371

[8] Costs, quality of life and disease severity in multiple sclerosis:: a cross-sectional study in Sweden [J].

Henriksson, F ;

Fredrikson, S ;

Masterman, T ;

Jönsson, B .

EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (01) :27-35

[9] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[10] Health-related quality-of-life measurement in patients with Parkinson's disease [J].

Jenkinson, C ;

Fitzpatrick, R ;

Peto, V .

PHARMACOECONOMICS, 1999, 15 (02) :157-165